Gene Cell Nano
GeneCellNano Flagship develops new biological drugs, so-called ATMP products, biomarkers and diagnostics for diseases with unmet clinical need. New treatments are developed for cardiovascular diseases and age-related macular degeneration, as well as for brain, ovarian and bladder cancer.
News
- New EIC-funded NutriEV project studies nutrient-enriched extracellular vesicles
- Save the date for the Fourth Annual Meeting!
- Significant funding from Business Finland for retinopathy treatment research
- FinVector’s new gene therapy manufacturing hub opened in Kuopio
- University of Eastern Finland to participate in European alliance for rare disease research
GeneCellNano is an interdisciplinary community of top experts specialized in biological Advanced Therapy Medicinal Products (ATMP) and nanotechniques linked with their management.
